期刊文献+

妊娠期高血压疾病患者血浆内皮素与血小板聚集率的相关性分析 被引量:3

The relationship of ET and the blood platelet aggregate rate in plasmaon hypertensive disorders in pregnancy
暂未订购
导出
摘要 目的探讨内皮素(endothelin,ET)及血小板聚集率在妊娠期高血压疾病中的作用及关系。方法用放射免疫法及血凝测试仪同时抽血测定55例正常妊娠组及55例妊娠期高血压疾病组血浆中的ET及血小板聚集率。结果妊娠期高血压疾病组较正常妊娠组ET升高(P<0.01),血小板聚集率增高(P<0.05);妊娠期高血压疾病组间比较随着妊娠期高血压疾病的加重,ET及血小板聚集率呈逐渐增高趋势(P<0.05);直线相关分析表明:随着妊娠期高血压疾病的加重,ET与血小板聚集率的关系越密切,呈正相关(r1=0.478,P<0.05;r2=0.612,P<0.01;r3=0.732,P<0.01)。结论妊娠期高血压疾病患者存在着内皮细胞功能紊乱,内皮素增加血小板聚集率增高,且二者与妊娠期高血压疾病的程度密切相关。内皮素与血小板可能参与了妊娠期高血压疾病的发生发展,因此测定内皮素与血小板聚集率有助于妊娠期高血压疾病的诊断和治疗。 Objective To probe into the role and the relationship of ET and the Blood Platelet Aggregate Rate in plasma in the development of hypertensive disorders in pregnancy. Methods The level of ET and BPAR in plasma were measured with radio-immunity and a blood coagulation test instrument in 55 cases of normal group and 55 cases of hypertensive disorders in pregnancy group. Results Compared with the pregnant group,ET and BPAR increased respectively (P〈0.01 ,P〈0.05)in the hypertensive disorders in pregnancy group.Compared within the hypertensive disorders in pregnancy group,ET and BPAR showed an increasing trend as long as the hypertensive disorders in pregnancy was getting worse (P〈0.05). Linear correlation analyse showed that the worse the hypertensive disorders in pregnancy was, the closer relationship of ET and BPAR was (r1=0.478, P〈0.05 ;r2=0.612, P〈0.01 ;r3=0.732, P〈0.01 ). Conclusion Patients with hypertensive disorders in pregnancy suffered from functional disorder of endothelium cell, an increasing of ET and BPAR and also,they had a close correlation with the degree of the hypertensive disorders in pregnancy. ET and BPAR may have taken part in the formation and development of the hypertensive disorders in pregnancy. Therefore, measurement of ET and BPAR will be helpful in the diagnosis and treatment of the hypertensive disorders in pregnancy.
出处 《基层医学论坛》 2012年第22期2874-2875,共2页 The Medical Forum
关键词 妊娠 高血压 内皮素 血小板聚集率 Pregnancy Hypertensive Endothelin Platelet aggregation rate
  • 相关文献

参考文献6

  • 1Shaaraway M, Didy HE.Thrombomodulin',plasminogen activator inhibitor type- 1 and fibronectin as biomarker of endothelial damage in preelampsia and eclampsia[J].Int J Gynecol Obstet, 1996,55 : 135-139.
  • 2Zeeman GG, Gerda G,Dekker GA.Pathogenesis of preeclampsia:a hypothesis[J].Clin Obstet Gynecol, 1992,35 ( 2 ): 317.
  • 3张爱臣,李雅然,王惠娟,李楷彬,冷维春,丁宝君.不同程度妊高征患者内皮素的变化[J].中华妇产科杂志,1994,29(1):2-4. 被引量:15
  • 4Granger JP,Alexander BT,Bennntt WA,et al.Pathophysiology of pregnancy-induced hypertension[J].Am J Hyper tens, 2001,14 (6 Pt 2): 178-185.
  • 5杨桂明,张凌慧,张荣辉,肖占森.妊娠高血压综合征与血浆中部分细胞因子关系的研究[J].现代妇产科进展,2001,10(4):273-275. 被引量:5
  • 6Strewart DJ. Increased plasma.endothlin-1 in the early hours of acute myocardial in action[J].JAC, 1991,18 : 38.

二级参考文献8

共引文献17

同被引文献51

  • 1曹学珍.糖尿病患者联合检测血流变和血小板聚集率的临床意义[J].中国医药导刊,2013,15(S1):18-19. 被引量:1
  • 2贺同强,窦凤鸣,苟文丽.钙通道与妊娠期高血压疾病关系的研究进展[J].国外医学(妇幼保健分册),2004,15(6):341-343. 被引量:3
  • 3Bourassa EA, Sved AF., Speth RC. Angiotensin modula- tion of rostral ventrolateral medulla(RVLM) in cardio- vascular regulation [J]. Mol cell Endocrinol, 2009, 302 (2) .167-175.
  • 4van den Born BJ, L6wenberg EC, van derHoeven NV, et al. Endothelial dysfunction, platelet activation, thromho- genesis and fibrinolysis in patients with hypertensive cri- sis[J]. J Hypertens,2011,29(5) :922-927.
  • 5Yang P, Liu YF, Yang L, et al. Mechanism and clinical signifyance of the prothrombotic state in patientswith es- sential hypertension[J]. Clin Cardiol, 2010,33 (6) : 81-86.
  • 6Steinhubl SR,Moliterno DJ.The role of the platelet in the pathogenesis of atherothrombosis[J].Am J Cardiovasc Drugs,2005,5(6):399-408.
  • 7Furie B,Furie BC.Mechanisms of thrombus formation[J].N Engl J Med,2008,359(9):938-949.
  • 8Frossard M,Fuchs I,Leitner JM,et al.Platelet function predicts myocardial damage in patients with acute myocardial infarction[J].Circulation,2004,110(11):1392-1397.
  • 9Gasparyan AY.Aspirin and clopidogrel resistance:methodological challenges and opportunities[J].Vasc Health Risk Manag,2010,6:109-112.
  • 10Sharma RK,Voelker DJ,Sharma R,et al.Evolving role of platelet function testing in coronary artery interventions[J].Vasc Health Risk Manag,2012,8:65-75.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部